NasdaqGS - Nasdaq Real Time Price USD
Werewolf Therapeutics, Inc. (HOWL)
As of 12:21 PM EDT. Market Open.
Research Analysis
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 6 | 6 |
| Avg. Estimate | -0.41 | -0.45 | -1.65 | -1.94 |
| Low Estimate | -0.45 | -0.83 | -2.07 | -4.45 |
| High Estimate | -0.36 | -0.31 | -1.41 | -1.03 |
| Year Ago EPS | -0.23 | -0.33 | -1.05 | -1.65 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 6 | 6 |
| Avg. Estimate | 710k | 1.15M | 3.44M | 10.03M |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | 2.26M | 4.88M | 9.02M | 50M |
| Year Ago Sales | -- | 1.5M | 19.94M | 3.44M |
| Sales Growth (year/est) | -- | -23.40% | -82.80% | 191.60% |
Earnings History
| CURRENCY IN USD | 9/30/2023 | 12/31/2023 | 3/31/2024 | 6/30/2024 |
|---|---|---|---|---|
| EPS Est. | -0.39 | -0.43 | -0.35 | -0.38 |
| EPS Actual | -0.23 | -0.33 | -0.39 | -0.4 |
| Difference | 0.16 | 0.1 | -0.04 | -0.02 |
| Surprise % | 41.00% | 23.30% | -11.40% | -5.30% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.41 | -0.45 | -1.65 | -1.94 |
| 7 Days Ago | -0.41 | -0.45 | -1.65 | -1.94 |
| 30 Days Ago | -0.41 | -0.45 | -1.65 | -1.94 |
| 60 Days Ago | -0.4 | -0.38 | -1.56 | -1.44 |
| 90 Days Ago | -0.37 | -0.39 | -1.54 | -1.49 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | HOWL | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -78.30% | -- | -- | 4.40% |
| Next Qtr. | -36.40% | -- | -- | 7.80% |
| Current Year | -57.10% | -- | -- | 2.50% |
| Next Year | -17.60% | -- | -- | 13.10% |
| Next 5 Years (per annum) | 10.90% | -- | -- | 11.89% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 7/2/2024 |
| Reiterates | JMP Securities: Market Outperform to Market Outperform | 6/26/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 6/26/2024 |
| Reiterates | JMP Securities: Market Outperform to Market Outperform | 6/4/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 6/3/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/24/2024 |
Related Tickers
IKNA Ikena Oncology, Inc.
1.7000
-0.58%
GLUE Monte Rosa Therapeutics, Inc.
5.39
+5.27%
RLYB Rallybio Corporation
1.1200
+2.75%
XLO Xilio Therapeutics, Inc.
0.8100
+1.25%
TNYA Tenaya Therapeutics, Inc.
1.7450
+3.25%
ELEV Elevation Oncology, Inc.
0.5566
+7.24%
ALXO ALX Oncology Holdings Inc.
1.5800
+1.28%
CGEM Cullinan Therapeutics, Inc.
17.43
+7.30%
DSGN Design Therapeutics, Inc.
5.66
+5.01%
VOR Vor Biopharma Inc.
0.6691
+3.85%